Paper Title
ASSESSMENT OF PNEUMONIA MANAGENTOFUNDER- FIVE CHILDRENAT BOLE BULBULA HEALTH CENTER, ADDIS ABABA, ETHIOPIA, 2024
Article Identifiers
Registration ID: IJNRD_219556
Published ID: IJNRD2405226
: Click Here to Get
About Hard Copy and Transparent Peer Review Report
Authors
Keywords
:-Adherence to management Drug Evaluation, Amoxicillin, pneumonia
Abstract
Abstract Introduction: - Pneumonia remains the leading cause of child mortality resulting from infectious diseases worldwide. Particularly in Ethiopia, pneumonia continues to be the primary cause of death among children under the age of five. The high prevalence of pneumonia and its significant financial implications highlight the importance of accurate diagnosis and appropriate management of patients. It is crucial to diagnose pneumonia precisely and use antibiotics judiciously to address the growing crisis of antibiotic resistance. When initial antibiotics become ineffective due to microbial resistance, more expensive medications must be used. This leads to prolonged illness and treatment, often requiring hospitalization, which not only increases healthcare expenses but also imposes a substantial economic burden on families and societies. Numerous studies have shown that adherence to treatment guidelines can reduce morbidity, mortality, and healthcare costs. Guidelines play a critical role in directing and standardizing the management of pneumonia. However, there is evidence suggesting that national guidelines for pneumonia management are frequently disregarded in clinical practice. Objective: - To assess the extent of adherence to treatment guidelines in the management of pneumonia in under-5 OPD of Bole Bulbula health center, Addis Ababa, Ethiopia, From January 2023 to January 2024. Methodology: - The study involved the review of one hundred twenty charts of children under five at Bole Bulbula Health Center under 5 OPD as secondary data. Children's card numbers were selected using systematic random sampling from the under-five outpatient department and sent to the card room to retrieve individual folders. Data were collected directly from the individual folders using a structured questionnaire prepared by Kobo Toolbox for data collection. Results: - The majority of the children (56, 46.7%) received treatment for pneumonia with Amoxicillin suspension, while another group of children (50, 41.7%) were treated with Amoxicillin dispersible tablets. A small number of children (3, 2.5%) were treated with Azithromycin syrup, and the remaining children (11, 9.2%) received other medications. All of the children (56, 100%) were managed with the standard dose of Amoxicillin suspension (30-50mg/kg), and all 50 (100%) children received the standard dose of amoxicillin dispersible tablets. All of children (106, 100%) were given Amoxicillin Dispersible tablet or suspension for 5-7 days, and there were no contraindications for this medication among any of the children. Additionally, there were no reported drug interactions with Amoxicillin suspension. The full names, qualifications, signatures, and dates of the prescribers were documented in the individual folders of 84 (70%), 63 (52.5%), 117 (97.5%), and 114 (95%) children, respectively. Out of these, sixty-six (55%) were male and fifty-four (45%) were female. The average age of the individuals was 1.33 years (95% CI: 0.1-2.59). Their average weight was 8.3 kilograms (95% CI: -4.5-18).None of the children's length, their head circumference and MUAC were not measured. Conclusion: The utilization of the first-line drug amoxicillin dispersible tablet at Bole Bulbula Health Center was found to be inadequate. However, the treatment approach for managing pneumonia in children under 5 years old at the OPD of BBHC through first line, 2nd line and alternative drug was relatively satisfactory. The Duration Of treatment for under five children’s treated with the recommended drugs duration were appropriate.
Downloads
How To Cite (APA)
YALELET CHANIE MILASHU, GETAHUN SISAY, FREHIWOT ZERIHUN, KALEB KASTRO, & REBIRA JISA,BIRHANU MEKONNEN (May-2024). ASSESSMENT OF PNEUMONIA MANAGENTOFUNDER- FIVE CHILDRENAT BOLE BULBULA HEALTH CENTER, ADDIS ABABA, ETHIOPIA, 2024. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(5), c222-c232. https://ijnrd.org/papers/IJNRD2405226.pdf
Issue
Volume 9 Issue 5, May-2024
Pages : c222-c232
Other Publication Details
Paper Reg. ID: IJNRD_219556
Published Paper Id: IJNRD2405226
Research Area: Pharmacy
Author Type: Foreign Author
Country: Addis Ababa , Addis Ababa , Ethiopia
Published Paper PDF: https://ijnrd.org/papers/IJNRD2405226.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405226
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use.
The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.
For Indian Authors : Get a transparent peer review report from Scholar9.com for just ₹1000. View Sample Report
For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report
Transparent Peer Review Journal Publication
⭐ Transparent Peer Review | 🕵️♂️ Double-Blind | 👨🏫 3000+ Expert Reviewers | 🇮🇳 Report for India Author ₹1000 | 🌐 Report for Foreign Author $20 | 📄 Sample Reports on Scholar9.com | 🌍 High Credibility | ⚖️ Ethical & Unbiased Evaluation
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.
You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.
For more details, refer to the official notice: UGC Public Notice
⭐ Low Cost ₹1570 | 📚 UGC CARE Approved | 🔍 Peer-Reviewed | 🌐 Open Access | 🔗 Crossref DOI & Global Indexing | 📊 Google Scholar Impact Factor | 🧪 Multidisciplinary
Submit Paper Online Call for Paper About IJNRD UGC CARE Approval
Important Dates for Current issue
Paper Submission Open For: February 2026
Current Issue: Volume 11 | Issue 2 | February 2026
Impact Factor: 8.76
Last Date for Paper Submission: Till 28-Feb-2026
Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.
Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.
Subject Category: Research Area
Approval, Licenses and Indexing: More Details
Call For Paper - Volume 11 | Issue 2 | February 2026
IJNRD.org offers low-cost journal publication starting at ₹1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.
Volume 11 | Issue 2 | February 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online
⭐ UGC CARE Approved Refereed Journal | 🔍 Transparent Peer Review | 🌐 Open Access Publishing | 💰 Low-Cost ₹1570 | 🔗 CrossRef DOI & Global Indexing | 📊 Google Scholar Impact Factor 8.76 | 🧪 Multidisciplinary | Online & Print
Submit Paper Online
